December 23, 2025 · Form 4 insider transaction
MALCOLM JAN sold 50 shares of United Therapeutics Corporation at $512.12 per share, a transaction worth $25.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 11, 2025.